| Bioactivity | (R)-Zanubrutinib is the R enantiomer of Zanubrutinib. Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor. | ||||||||||||
| Name | (R)-Zanubrutinib | ||||||||||||
| CAS | 1691249-44-1 | ||||||||||||
| Formula | C27H29N5O3 | ||||||||||||
| Molar Mass | 471.55 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Wu J, et al. Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor. J Hematol Oncol. 2016 Mar 9;9:21. [2]. Wu J, et al. Second-generation inhibitors of Bruton tyrosine kinase. J Hematol Oncol. 2016 Sep 2;9(1):80. |
(R)-Zanubrutinib
CAS: 1691249-44-1 F: C27H29N5O3 W: 471.55
(R)-Zanubrutinib is the R enantiomer of Zanubrutinib. Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.